Variant position: 387 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 435 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human DTEVRSRVVGGSLRGAQAAS PAKGEPSLP-EKDEDHALSYWK
Mouse DTEVRRRMVGGGLQSAQASV PTEEELSSTEEEHKAHWPSHW
Rat DTEVRKRMVGGGLQSAQASV PTEEELSPTEEEQKAHRPVHW
Chicken DTEIRRRTVGENL---HVTA HKEESKSESVEEDDENMMTTW
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 435 Tyrosine-protein phosphatase non-receptor type 1
378 – 398 Disordered
368 – 368 Phosphothreonine
378 – 378 Phosphoserine; by PKC
386 – 386 Phosphoserine; by CDK1
Protein tyrosine phosphatase 1B variant associated with fat distribution and insulin metabolism.
Ukkola O.; Rankinen T.; Lakka T.; Leon A.S.; Skinner J.S.; Wilmore J.H.; Rao D.C.; Kesaeniemi Y.A.; Bouchard C.;
Obes. Res. 13:829-834(2005)
Cited for: ASSOCIATION OF VARIANT LEU-387 WITH LOW GLUCOSE TOLERANCE;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.